Bachem (BCHMF) Stock Price, News & Analysis

Company Overview

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.

Key Stats

• Today's Range: $61.43 to $61.43
• 50-Day Range: $61.43 to $64.05
• 52-Week Range: $61.43 to $74.45
• Volume: N/A
• Average Volume: 2,600 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BCHMF Stock Analysis - Frequently Asked Questions

How have BCHMF shares performed this year?

Bachem's stock was trading at $63.00 on January 1st, 2025. Since then, BCHMF stock has decreased by 2.5% and is now trading at $61.4275.
View the best growth stocks for 2025 here.

How do I buy shares of Bachem?

Shares of BCHMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/28/2025
• Next Earnings (Estimated): 7/24/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Basic Materials
• Industry: Chemicals
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BCHMF
• CIK: N/A
• Web: www.bachem.com
• Phone: 41-58-595-2021
• Fax: N/A
• Employees: 2,006
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A